Resistance Training and Testosterone Levels in Male Patients with Chronic Kidney Disease Undergoing Dialysis
Table 3
Hormone levels for those patients who completed the intervention (). The 16-week control period was measured from the baseline test to the pretraining test, and the 16-week training period was measured from the pretraining to the posttraining test.
Variables
Baseline ()
Pretraining ()
Posttraining ()
P control period
P training period
P between periods
Total T (nmol/L)
21.7 (8.2–52.1)
18.7 (7.8–54.7)
19.8 (7.2–57.7)
0.695
0.326
0.099
Free T (pmol/L)
485 (141–1057)
474 (177–820)
524 (240–776)
0.695
0.530
0.347
IGF-1 (ng/mL)
203 (138–590)
246 (108–811)
201 (113–606)
0.346
0.272
0.388
IGF-BP3 (ng/mL)
4905 (3600–9370)
4740 (3610–9760)
4525 (3550–8900)
0.754
0.844
0.937
IGF-1/IGF-BP3
0.0443 (0.0313–0.0630)
0.0461 (0.0262–0.0831)
0.0423 (0.0267–0.0895)
0.433
0.182
0.347
SHBG (nmol/L)
42.5 (13.0–66.0)
35.0 (11.0–80.0)
38.5 (8.0–83.0)
0.235
0.366
0.239
LH (U/L)
13.4 (5.5–57.2)
15.8 (5.6–58.7)
14.4 (5.5–52.0)
1.000
0.424
0.477
FSH (U/L)
10.5 (4.1–86.1)
9.7 (3.9–84.0)
8.9 (3.3–83.7)
1.000
0.272
1.000
Total T/LH
1.83 (0.18–5.01)
1.55 (0.24–2.86)
1.82 (0.34–3.70)
0.084
0.110
0.041
Estradiol (pmol/L)
101 (75–133)
104 (70–113)
101 (68–125)
0.432
0.694
0.638
Inhibin-B (pg/mL)
170 (1–342)
162 (1–380)
172 (1–355)
0.929
0.721
0.575
Inhibin-B/FSH
15.35 (0.01–83.82)
15.77 (0.01–88.99)
20.31 (0.01–107.90)
0.937
0.136
0.209
Data are presented as median (range). T: testosterone; SHBG: sex hormone-binding globulin; DHEA: dehydroepiandrosterone; AMH: anti-Müllerian hormone.
